المؤلفون: Harousseau Jl, Régis Bataille, Françoise Accard, Catherine Pellat-Deceunynck, Martine Amiot, Denis Puthier, Danielle Pineau, Nelly Robillard, Gaëtan Jego

المساهمون: Spinelli, Lionel, Lipides - Nutrition - Cancer (U866) (LNC), Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon (ENSBANA), On behalf of the IFM group, Service d'Hématologie Clinique [Hôtel Dieu, Nantes], Hôtel-Dieu de Nantes, Nutrition, obésité et risque thrombotique (NORT), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Lipides - Nutrition - Cancer (U866) ( LNC ), Université de Bourgogne ( UB ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Ecole Nationale Supérieure de Biologie Appliquée à la Nutrition et à l'Alimentation de Dijon ( ENSBANA ), Nutrition, obésité et risque thrombotique ( NORT ), Aix Marseille Université ( AMU ) -Institut National de la Recherche Agronomique ( INRA ) -Institut National de la Santé et de la Recherche Médicale ( INSERM )

المصدر: Europe PubMed Central
Blood
Blood, American Society of Hematology, 1999, 94 (2), pp.701--712
Blood, 1999, 94 (2), pp.701--712

مصطلحات موضوعية: Male, Cellular differentiation, Remission, Spontaneous, Apoptosis, CD38, Plasma cell, Biochemistry, 0302 clinical medicine, immune system diseases, hemic and lymphatic diseases, Child, Cells, Cultured, [INFO.INFO-BI] Computer Science [cs]/Bioinformatics [q-bio.QM], 0303 health sciences, biology, Antibodies, Monoclonal, Cell Differentiation, Hematology, Middle Aged, medicine.anatomical_structure, Female, Antibody, Multiple Myeloma, Adult, Plasma Cells, Immunology, Lymphocytosis, CD19, Immunophenotyping, Immunoglobulin kappa-Chains, 03 medical and health sciences, Immunoglobulin lambda-Chains, Antigens, CD, [ INFO.INFO-BI ] Computer Science [cs]/Bioinformatics [q-bio.QM], medicine, Humans, Progenitor cell, Aged, Retrospective Studies, 030304 developmental biology, CD40, Interleukin-6, Plasmacytosis, Cell Biology, medicine.disease, Hematopoietic Stem Cells, Molecular biology, Receptors, Interleukin-6, biology.protein, [INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM], 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94ce0f730558d336e9112042bc6a3983Test
http://europepmc.org/abstract/med/10397737Test

المؤلفون: Vanessa Bolejack, Michel Attal, Meletios A. Dimopoulos, Jesús F. San Miguel, Douglas E. Joshua, Pieter Sonneveld, Rafael Fonseca, Robert A. Kyle, Bart Barlogie, Joan Bladé, Chaim Shustik, Michele Cavo, Jan Westin, Heinz Ludwig, Kazuyuki Shimizu, Antonio Palumbo, John Crowley, Mario Boccadoro, Brian G.M. Durie, Philip R. Greipp, Meral Beksac, Ingemar Turesson, Jean Luc Harousseau

المساهمون: Radiology & Nuclear Medicine, Hematology, Ludwig H, Durie BG, Bolejack V, Turesson I, Kyle RA, Blade J, Fonseca R, Dimopoulos M, Shimizu K, San Miguel J, Westin J, Harousseau JL, Beksac M, Boccadoro M, Palumbo A, Barlogie B, Shustik C, Cavo M, Greipp PR, Joshua D, AttalM, Sonneveld P, Crowley J.

المصدر: Blood, 111(8), 4039-4047. American Society of Hematology

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Clinical Trials and Observations, International Cooperation, Immunology, Biochemistry, Age Distribution, Risk Factors, Internal medicine, medicine, Autologous transplantation, Humans, Stage (cooking), Risk factor, Survival rate, Survival analysis, Multiple myeloma, Aged, Aged, 80 and over, Hematology, biology, business.industry, C-reactive protein, Cell Biology, Middle Aged, medicine.disease, Prognosis, Survival Analysis, Surgery, Cytogenetic Analysis, Multivariate Analysis, biology.protein, Female, business, Multiple Myeloma

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::996cd52b4fc5678ac74fbf607805ec9fTest
https://hdl.handle.net/1765/29132Test

المؤلفون: Paul G. Richardson, Helgi van de Velde, Jean-Luc Harousseau, Dixie-Lee Esseltine, Rudolf Schlag, Maria-Victoria Mateos, Antonio Palumbo, Ofer Shpilberg, Andrew Cakana, Kevin Liu, Jesús F. San Miguel, Alain Kentos, Anatoly Golenkov, Meletios A. Dimopoulos, Martin Kropff, Mieczysław Komarnicki, Michele Cavo, William Deraedt

المساهمون: Harousseau JL, Palumbo A, Richardson PG, Schlag R, Dimopoulos MA, Shpilberg O, Kropff M, Kentos A, Cavo M, Golenkov A, Komarnicki M, Mateos MV, Esseltine DL, Cakana A, Liu K, Deraedt W, van de Velde H, San Miguel JF.

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname

مصطلحات موضوعية: Melphalan, Male, medicine.medical_specialty, Time Factors, medicine.drug_class, Immunology, Urology, Kaplan-Meier Estimate, Biochemistry, Bortezomib, chemistry.chemical_compound, Prednisone, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Multiple myeloma, Aged, Very Good Partial Response, business.industry, Hazard ratio, Remission Induction, Cell Biology, Hematology, Middle Aged, medicine.disease, Prognosis, Boronic Acids, Nitrogen mustard, Surgery, Treatment Outcome, chemistry, Pyrazines, Multivariate Analysis, Corticosteroid, Female, business, Multiple Myeloma, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b7575c14625ec3fee0597f02beab88Test
http://hdl.handle.net/10261/63102Test

المؤلفون: Harousseau, Jean-Luc, Martinelli, Giovanni, Jedrzejczak, Wieslaw W, Brandwein, Joseph M, Bordessoule, Dominique, Masszi, Tamas, Ossenkoppele, Gert J, Alexeeva, Julia A, Beutel, Gernot, Maertens, Johan, Vidriales, Maria-Belen, Dombret, Hervé, Thomas, Xavier, Burnett, Alan K, Robak, Tadeusz, Khuageva, Nuriet K, Golenkov, Anatoly K, Tothova, Elena, Mollgard, Lars, Park, Youn C, Bessems, Annick, De Porre, Peter, Howes, Angela J, Renseigné, Non

المساهمون: Service d'Hématologie clinique et thérapie cellulaire [CHU Limoges], CHU Limoges, Service d'Hématologie biologique [CHU Limoges], Université de Limoges (UNILIM), Physiologie Moléculaire de la Réponse Immune et des Lymphoproliférations (PMRIL), Université de Limoges (UNILIM)-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Centre National de la Recherche Scientifique (CNRS), Lymphocyte et cancer, IFR105-Institut National de la Santé et de la Recherche Médicale (INSERM), Génétique, immunothérapie, chimie et cancer (GICC), UMR 6239 CNRS [2008-2011] (GICC UMR 6239 CNRS), Université de Tours-Centre National de la Recherche Scientifique (CNRS), Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Harousseau JL, Martinelli G, Jedrzejczak WW, Brandwein JM, Bordessoule D, Masszi T, Ossenkoppele GJ, Alexeeva JA, Beutel G, Maertens J, Vidriales MB, Dombret H, Thomas X, Burnett AK, Robak T, Khuageva NK, Golenkov AK, Tothova E, Mollgard L, Park YC, Bessems A, De Porre P, Howes AJ., Hematology, CCA - Innovative therapy

المصدر: Harousseau, J L, Martinelli, G, Jedrzejczak, W W, Brandwein, J M, Bordessoule, D, Masszi, T, Ossenkoppele, G J, Alexeeva, J A, Beutel, G, Maertens, J, Vidriales, M B, Dombret, H, Thomas, X, Burnett, A K, Robak, T, Khuageva, N K, Golenkov, A K, Tothova, E, Mollgard, L, Park, Y, Bessems, A, De Porre, P & Howes, A J 2009, ' A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older ', Blood, vol. 114, no. 6, pp. 1166-1173 . https://doi.org/10.1182/blood-2009-01-198093Test
Blood
Blood, American Society of Hematology, 2009, 114 (6), pp.1166-73. ⟨10.1182/blood-2009-01-198093⟩
Blood, 114(6), 1166-1173. American Society of Hematology

مصطلحات موضوعية: Male, Time Factors, Administration, Oral, Phases of clinical research, Quinolones, TIPIFARNIB, Biochemistry, 0302 clinical medicine, MESH: Aged, 80 and over, Clinical endpoint, Hydroxyurea, Secondary Acute Myeloid Leukemia, Aged, 80 and over, MESH: Aged, 0303 health sciences, Hazard ratio, Hematology, MESH: Hydroxyurea, 3. Good health, Survival Rate, Leukemia, Myeloid, Acute, 030220 oncology & carcinogenesis, MESH: Administration, Oral, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, MESH: Leukemia, Myeloid, Acute, medicine.drug, medicine.medical_specialty, Neutropenia, MESH: Neutropenia, MESH: Survival Rate, Immunology, Antineoplastic Agents, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Humans, ACUTE MYELOID LEUKEMIA (AML), Survival rate, Aged, 030304 developmental biology, MESH: Humans, MESH: Quinolones, business.industry, MESH: Time Factors, Cell Biology, medicine.disease, MESH: Male, Surgery, MESH: Disease-Free Survival, MESH: Antineoplastic Agents, Tipifarnib, business, MESH: Female, Febrile neutropenia

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c75c4c64781116ccf47026aa553bf0fTest
http://hdl.handle.net/11573/32513Test